• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number VBJR080502A
Device Problem Insufficient Information (3190)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/07/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).A review of the manufacturing records for the device verified the lot met all pre-release specifications.According to the gore® viabahn® endoprosthesis with heparin bioactive surface instructions for use (ifu),complications and adverse events can occur when using any endovascular device.These complications include, but are not limited to: migrations.
 
Event Description
The following information was reported to gore: on (b)(6) 2017 a patient was undergoing treatment of a left arm av access proximal graft to distal subclavian vein thrombotic occlusion with apparent extravasation seen on contrast angio.A gore® viabahn® endoprosthesis with heparin bioactive surface was advanced over a.035" glidewire through a 7fr sheath.On (b)(6) 2017 it was reported imaging showed no viabahn in the area expected.Further imaging showed the viabahn in the superior vena cava.The patient is reportedly stable and there are no current plans for reintervention.
 
Manufacturer Narrative
Updated.
 
Event Description
On (b)(6) 2017 a patient was undergoing treatment of a left arm av access procedure.A gore® viabahn® endoprosthesis with heparin bioactive surface was advanced over a.035" glidewire through a 7fr sheath and deployed in the axillary vein, across the anastomosis with the av graft.Following the procedure, the viabahn was well-apposed to the both the axillary vein and the av graft.On (b)(6) 2017 it was reported imaging showed no viabahn in the area expected.Further imaging showed the viabahn in the pulmonary artery.On an unknown date the viabahn was explanted by an interventional radiologist through the internal jugular vein.The patient is reportedly doing well and is receiving dialysis treatments via a permacath.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7144564
MDR Text Key95915196
Report Number2017233-2017-00674
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/07/2020
Device Catalogue NumberVBJR080502A
Device Lot Number16519337
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/08/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age64 YR
Patient Weight114
-
-